IP50-30: Contemporary analysis on patients with non-muscle invasive bladder cancer harboring CIS: results from 10-years of follow-up
Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Registered attendees

Scott Flanders
VP of Medical AffairsImmunityBio, Inc.